Prenetics Global Ltd (PRE) stock
PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 10/30
$16.33+0.85 (+5.49%)
Close on Nov 17, 2026Market cap $275.55MP/E –Yield –
Prenetics Global r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $5.13M, down 43.3% from the year before. The highest annual figure on record is $9.17M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.13M | -43.3% |
| FY2024 | Dec 31, 2024 | $9.05M | -1.3% |
| FY2023 | Dec 31, 2023 | $9.17M | +53.1% |
| FY2022 | Dec 31, 2022 | $5.99M | -6.3% |
| FY2021 | Dec 31, 2021 | $6.39M | +129.7% |
| FY2020 | Dec 31, 2020 | $2.78M | – |
See a number that looks wrong?